Table 2. Relationship between the expression of epigenetic-related genes and clinical characteristics.
| Gene symbol | Age (≥65/<65) | Gender (male/female) | Pathological stage (IV-III/ I–II) | T stage (T3–T4/T1–T2) | N stage (N2–3/N0-N1) | M stage (M1/ M0) |
| t(P) | t(P) | t(P) | t(P) | t(P) | t(P) | |
| ARRB1 | -1.513(0.131) | -1.635(0.103) | 1.487(0.139) | 0.507(0.614) | 1.17(0.243) | 0.395(0.697) |
| PARP1 | 0.934(0.351) | -0.761(0.447) | -0.344(0.732) | -0.269(0.789) | -0.628(0.531) | -1.23(0.233) |
| YWHAZ | 0.369(0.713) | -1.728(0.085) | -2.189(0.031) | -1.72(0.092) | -1.302(0.194) | -0.694(0.495) |
| TFDP1 | 1.113(0.267) | -1.077(0.283) | -1.035(0.304) | 1.155(0.249) | -1.083(0.281) | -1.029(0.316) |
| PKM | -1.609(0.109) | -0.663(0.508) | -2.865(0.005) | -1.936(0.059) | -3.006(0.003) | -1.352(0.191) |
| riskScore | 0.612(0.541) | -1.205(0.229) | -3.031(0.003) | -2.092(0.042) | -2.704(0.008) | -1.997(0.060) |
Note: t: t value of student's t test; P: P-value of student's t test.